Interleukin-6 Receptor Blockade Selectively Reduces IL-21 Production by CD4 T Cells and IgG4 Autoantibodies in Rheumatoid Arthritis
Open Access
- 1 January 2013
- journal article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 9 (3), 279-288
- https://doi.org/10.7150/ijbs.5996
Abstract
Interleukin-6 (IL-6) levels are known to be increased in patients with rheumatoid arthritis (RA). Tocilizumab, a monoclonal antibody to the IL-6 receptor (IL-6R), reduces disease activity in RA, although its mechanisms of action remain unclear. Since IL-6 regulates cytokine production by CD4 T cells during activation, we investigated whether treatment with tocilizumab altered the phenotype and cytokine production by CD4 T cells in patients with rheumatoid arthritis. We show here that tocilizumab treatment does not change the production of cytokines by naïve CD4 T cells. However, tocilizumab treatment causes a selective decrease of IL-21 production by memory/activated CD4 T cells. Since IL-21 is known to promote plasma cell differentiation, we examined the effect of tocilizumab on the production of autoantibodies. We show that there is a decrease in the levels of IgG4 anti-CCP antibodies, but there is no effect on IgG1 anti-CCP antibodies. In addition, we show that IL-21 is a powerful inducer of IgG4 production by B cells. Thus, IL-6 contributes to the presence of IgG4-specific anti-CCP autoantibodies in RA patients, likely through its effect on IL-21 production by CD4 T cells, and IL-6R blockade down-regulates this pathway.Keywords
This publication has 54 references indexed in Scilit:
- Interleukin-6: from an inflammatory marker to a target for inflammatory diseasesTrends in Immunology, 2012
- Special issue on Interleukin-6 (IL-6)International Journal of Biological Sciences, 2012
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6International Journal of Biological Sciences, 2012
- Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory DiseasesInternational Journal of Biological Sciences, 2012
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cellsThe Journal of Experimental Medicine, 2009
- The effects of IL-6 on CD4 T cell responsesClinical Immunology, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- Induction of NFATc2 Expression by Interleukin 6 Promotes T Helper Type 2 DifferentiationThe Journal of Experimental Medicine, 2002
- Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1Immunity, 2000